These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12002985)

  • 1. Meningococcal disease: oh no, not another childhood vaccine.
    Weir E
    CMAJ; 2002 Apr; 166(8):1064-6. PubMed ID: 12002985
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.
    Can Commun Dis Rep; 2006 Apr; 32(8):97-107. PubMed ID: 16685767
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
    Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
    Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
    CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
    [No Abstract]   [Full Text] [Related]  

  • 5. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 6. Meningococcal disease in Canada. Surveillance summary to 1987.
    Varughese PV; Carter AO
    Can Dis Wkly Rep; 1989 Apr; 15(17):89-96. PubMed ID: 2720807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control.
    Can Fam Physician; 1994 Dec; 40():2121-3. PubMed ID: 7888825
    [No Abstract]   [Full Text] [Related]  

  • 8. An Advisory Committee Statement (ACS). Statement on recommended use of meningococcal vaccines.
    National Advisory Committee on Immunisation (NACI)
    Can Commun Dis Rep; 2001 Oct; 27():2-36. PubMed ID: 11706686
    [No Abstract]   [Full Text] [Related]  

  • 9. Modern trends in mortality from meningococcal disease in Australia.
    Simpkins D; Wood N; Jelfs J; McIntyre PB; Menzies R; Lawrence G; Booy R
    Pediatr Infect Dis J; 2009 Dec; 28(12):1119-20. PubMed ID: 19858774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for controlling meningococcal disease.
    CMAJ; 1992 Mar; 146(6):939-42, 945-8. PubMed ID: 1544081
    [No Abstract]   [Full Text] [Related]  

  • 11. Travelers' protection against meningococcal disease: a new vaccine option.
    Black S
    J Travel Med; 2010; 17 Suppl():18-25. PubMed ID: 20849429
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
    De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH
    Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal C conjugate vaccination recommendations for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Nov; 33(ACS-11):1-12. PubMed ID: 18064747
    [No Abstract]   [Full Text] [Related]  

  • 15. Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.
    Squires SG; Pelletier L; Mungai M; Tsang R; Collins F; Stoltz J
    Can Commun Dis Rep; 2000 Nov; 26(21):177-82. PubMed ID: 11107657
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of serogroup C meningococcal conjugate vaccine: a 7-year follow-up in Quebec, Canada.
    De Wals P; Deceuninck G; Lefebvre B; Boulianne N; De Serres G
    Pediatr Infect Dis J; 2011 Jul; 30(7):566-9. PubMed ID: 21326136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe outbreak of meningococcal disease in Auckland.
    Jackson G; Lennon D; Voss L; Flight R
    N Z Med J; 1987 Apr; 100(821):226. PubMed ID: 3455492
    [No Abstract]   [Full Text] [Related]  

  • 19. Meningococcal disease in Newfoundland, 1967-1991.
    Can Commun Dis Rep; 1992 Aug; 18(15):116-7. PubMed ID: 1290995
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing protection against meningococcal disease.
    Reisinger KS; Black S; Stoddard JJ
    Clin Pediatr (Phila); 2010 Jun; 49(6):586-97. PubMed ID: 20089551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.